Stocks Listing
BLU

BELLUS Health Inc.

Share
BLU
$10.65 1.53%Last Updated Sep 28 2022 02:57 PM
1D Low / 1D High
Low:$10.54
High:$10.75
1D
1.53%
5D
0.56 %
30D
5.33 %
BulletPurple
Market Cap
$1,350,845,952
1.53 %
1.4 B
BulletBlue
Volume 1D
51,249
-
51.2 K
BulletOrange
Circulating Supply
126,839,995 BLU
126.8 M

Price Chart

1D
5D
1M
6M
YTD
1Y
MAX
About

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders. Its lead drug candidate includes BLU-5937, an oral small molecule antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of chronic cough and chronic pruritus. The company was founded in 1993 and is headquartered in Laval, Canada.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open - Close
Low/High
Volume
Market Cap
Show More
Market Status
Opened
NMS
NASDAQ Stock Exchange
USA
Closes in
4 hours, 42 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0